Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Using credit card points for travel discounts can lead to substantial savings. Learn how to leverage your points for your next adventure.
18,562 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
As March moves unfold, the stock market today is colored by big auto headlines. Ford’s recall news sent ripples throu...
Cisco is betting on AI infrastructure and recurring revenue to escape dot-com era fears. With rising ARR, rising subs...
In 2026, the equal-weight S&P 500 index has posted impressive breadth-driven gains, outpacing the cap-weight S&P 500 ...
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
Microsoft led a rebound among the Magnificent 7 as investors rotated back into software, while Apple and Alphabet sli...
A Goldman Sachs note presents a bullish scenario where gold could hit $5,400 per ounce. The outlook reverberates thro...
Investors are weighing three very different tech names as AI upgrades drive Nvidia higher while Qualcomm faces a toug...
As markets navigate 2026, investors cling to long-term tech exposure. A fresh look at VGT argues it can anchor retire...
Two AI infrastructure players, CoreWeave and Nebius, face off as compute demand climbs. This guide breaks down backlo...
As markets bounce between frenzy and caution, investors are weighing two paths: a focused bet on seven mega-cap names...
Institutional buyers returned to digital assets in force, with BlackRock at the helm, buying roughly $600 million in ...